Seven analysts set a EUR 20.00 target for Evonik stock
Published on 10/27/2026 at 17:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting date November 3, 2026
- Seven analysts set a 12-month consensus target of EUR 20.00 on October 20, 2026.
- Evonik is scheduled to report third-quarter 2026 results on November 3, 2026.
- Evonik stock costs EUR 21.34 at Lang & Schwarz on October 27, 2026 at 5:00 p.m. CEST, 0.19 percent above the Xetra close of October 26, 2026 at EUR 21.30.
- The 52-week range is EUR 12.49 to EUR 21.84, with market capitalization at EUR 10.0 billion.
Seven analysts put Evonik's 12-month consensus target at EUR 20.00 on October 20, 2026, with four of seven ratings at Hold, according to boerse-express. The price lies 6.28 percent above that target. Evonik's investor-relations page schedules the third-quarter 2026 report for November 3, 2026, according to Evonik. Evonik stock was trading at EUR 21.34 at Lang & Schwarz on October 27, 2026 at 5:00 p.m. CEST, up 0.19 percent versus the Xetra close of October 26, 2026 at EUR 21.30.
Consensus target stays below price
The analyst picture is cautious despite the stock's position near its yearly high. The EUR 20.00 median target from seven analyst houses is 6.28 percent below the October 27 price, while the published target range runs from EUR 14.00 to EUR 22.00.
The distribution also matters: two ratings are Buy, four are Hold and one is Sell. That split leaves the November results as the next scheduled test of whether operating progress can support the market's higher quotation.
Stock remains near yearly high
Evonik's 52-week range is EUR 12.49 to EUR 21.84 as of October 27, 2026. The Lang & Schwarz price is 2.29 percent below the high, while the market capitalization is EUR 10.0 billion and volume stands at 187,483 shares.
Evonik is listed on Xetra under ticker EVK and operates in specialty chemicals. Its portfolio includes specialty additives, nutrition and care, smart materials, performance materials, and technology and infrastructure.
November 3 brings the next test
The next scheduled corporate date is the third-quarter 2026 report on November 3, 2026. The investor-relations calendar also lists fourth-quarter 2026 reporting for March 4, 2027, but that later date is less immediate for the current valuation.
The key comparison is between a stock price close to its 52-week high and a consensus target below the market. The upcoming report can add a fresh operating reference, especially because the current analyst distribution remains weighted toward Hold rather than Buy.
Price stays close to the high
Evonik stock was trading at EUR 21.34 at Lang & Schwarz on October 27, 2026 at 5:00 p.m. CEST, 0.19 percent above the Xetra close of October 26, 2026 at EUR 21.30. The price was 2.29 percent below the 52-week high of EUR 21.84.
The further course of trading is shown by the continuously updated real-time quote of Evonik stock.
Evonik stock at a glance
- Company: Evonik Industries AG
- ISIN: DE000EVNK013
- WKN: EVNK01
- Ticker: EVK
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 27, 2026, 5:00 p.m. CEST): EUR 21.34
- Change versus Xetra close: plus 0.19 percent
- Xetra close (October 26, 2026): EUR 21.30
- Market capitalization: EUR 10.0 billion (as of October 27, 2026)
- 52-week range: EUR 12.49-EUR 21.84 (as of October 27, 2026)
- Sector / Industry: Basic Materials / Specialty Chemicals
- Next earnings date: November 3, 2026
Market context: Market report DAX.
